Search

everythinglearnresearchcommunity

for

Search:↓

One minoxidil-sensitive potassium channel exists in human hair follicles.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Using neurohormones to control keratin can lead to new skin disease treatments.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

People with alopecia areata often have lower vitamin D levels than healthy people.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.